Click Therapeutics wins breakthrough nod for PDT for migrain

Click Therapeutics announced that it received FDA breakthrough device designation for its CT-132 prescription digital therapeutic (PDT).

Related Keywords

Austin Speier , Shaheen Lakhan , Stewart Tepper , Geisel School Of Medicine At Dartmouth , Dartmouth Headache Center , Click Therapeutics , York Based Click , Click Neurobehavioral Intervention , Geisel School , Dartmouth Headache ,